INJ Jumps 10.7% as Injective Tops Solana and Ethereum on Revenue-to-FDV Ratio
- —INJ gained 10.7% over 24 hours, per CoinMarketCap
- —Revenue-to-FDV ratio: Injective 0.95, Solana 0.83, Arbitrum 0.78, Ethereum 0.11
- —Injective's ratio is 8.6x Ethereum's and 11.9x that of SUI and Avalanche
- —The network buys back INJ with onchain revenue and removes tokens from circulation
Why it matters: Strong revenue relative to valuation plus a buyback mechanism could support INJ's price if network income growth proves durable.
Source: Blockmedia